It’s Time To Focus On The Long Run With Vaxxinity Inc. (VAXX) stock

Vaxxinity Inc. (NASDAQ: VAXX) closed the day trading at $3.19 up 6.33% from the previous closing price of $3.00. In other words, the price has increased by $+0.1900 from its previous closing price. On the day, 5742430 shares were traded. VAXX stock price reached its highest trading level at $4.1000 during the session, while it also had its lowest trading level at $3.0500.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Ratios:

For a better understanding of VAXX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.30 and its Current Ratio is at 3.30. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.12.

Upgrades & Downgrades

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 02 when Prime Movers Lab Fund I LP sold 2,620 shares for $2.57 per share. The transaction valued at 6,729 led to the insider holds 2,160,502 shares of the business.

Prime Movers Lab Fund I LP sold 11,121 shares of VAXX for $28,561 on Dec 02. The 10% Owner now owns 9,169,589 shares after completing the transaction at $2.57 per share. On Dec 01, another insider, Prime Movers Lab Fund I LP, who serves as the 10% Owner of the company, sold 63,843 shares for $2.97 each. As a result, the insider received 189,722 and left with 2,163,122 shares of the company.

Stock Price History:

Over the past 52 weeks, VAXX has reached a high of $8.88, while it has fallen to a 52-week low of $1.24. The 50-Day Moving Average of the stock is 1.8020, while the 200-Day Moving Average is calculated to be 2.4540.

Shares Statistics:

Over the past 3-months, VAXX traded about 349.41K shares per day on average, while over the past 10 days, VAXX traded about 246.17k shares per day. A total of 126.04M shares are outstanding, with a floating share count of 49.46M. Insiders hold about 47.00% of the company’s shares, while institutions hold 23.40% stake in the company. Shares short for VAXX as of Oct 13, 2022 were 893.55k with a Short Ratio of 0.98M, compared to 728.5k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.71% and a Short% of Float of 2.64%.

Earnings Estimates

Current recommendations for the stock of the company come from 2 analysts. On average, analysts expect EPS of -$0.15 for the current quarter, with a high estimate of -$0.14 and a low estimate of -$0.17, while EPS last year was -$0.24. The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.13 and low estimates of -$0.18.

Analysts are recommending an EPS of between -$0.55 and -$0.65 for the fiscal current year, implying an average EPS of -$0.6. EPS for the following year is -$0.61, with 2 analysts recommending between -$0.57 and -$0.65.